Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Turenne Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 52
Average round size
info
The average size of a deal this fund participated in
$10M
Portfolio companies 46
Rounds per year 2.08
Lead investments 9
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.12
Exits 3
Key employees 3
Stages of investment
Early Stage Venture

Areas of investment

  • Software
  • Health Care
  • Biotechnology
  • Internet
  • Information Technology
Summary

In 1999 was created Turenne Capital, which is appeared as VC. The leading representative office of defined VC is situated in the Paris. The fund was located in Europe if to be more exact in France.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Turenne Capital, startups are often financed by Naxicap Partners, Innovacom, Highland Europe. The meaningful sponsors for the fund in investment in the same round are Paca Investissement, XAnge, Nord Capital. In the next rounds fund is usually obtained by XAnge, TempoCap, Sofimac Partners.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - France. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the various public portfolio startups of the fund, we may underline Notilo Plus, Fidzup, Dromadaire.com We can highlight the next thriving fund investment areas, such as Education, Software.

The real fund results show that this VC is 2 percentage points less often commits exit comparing to other companies. The top activity for fund was in 2018. The fund is constantly included in less than 2 deals per year. Opposing the other organizations, this Turenne Capital works on 22 percentage points less the average amount of lead investments. The higher amount of exits for fund were in 2016. The usual things for fund are deals in the range of 1 - 5 millions dollars.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Turenne Capital:
Typical Co-investors
Turenne Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Turenne Capital:

Funds with similar focus

Funds from France
Funds with similar focus located in France:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Antabio

Biotechnology
Life Science
Medical Device
$29M12 Dec 2023 France, Auvergne-Rhône-Alpes, France

AlgoTherapeutix

Biotechnology
Information Technology
Pharmaceutical
$23M14 Mar 2023 Suresnes, Ile-de-France, France

Amolyt Pharma

Health Care
Medical
Therapeutics
$153M06 Jan 2023 Écully, Rhone-Alpes, France

Domain Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$46M10 May 2022 France, Grand Est, France

PathoQuest

Biotechnology
Health Care
Therapeutics
$17M09 Nov 2021 Paris, Ile-de-France, France

AI Verse

Artificial Intelligence
Machine Learning
$2M01 Sep 2021 Sophia Antipolis, Provence-Alpes-Cote d'Azur, France

Biotechnology
Therapeutics
$23M14 Dec 2020 France, Provence-Alpes-Côte d'Azur

Exotrail

Computer
Information Technology
Logistics
Software
$13M16 Jul 2020 France, Ile-de-France

MCES

eSports
Gaming
Sports
Video Games
$2M05 Jul 2020 Marseille, Provence-Alpes-Côte d'Azur, France

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Turenne Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 52
Average round size 10M
Rounds per year 2.08
Peak activity year 2020
Lead investments 9
Follow on index 0.12
Exits 3
Group Appearance index 0.73

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Antabio

Biotechnology
Life Science
Medical Device
$29M12 Dec 2023 France, Auvergne-Rhône-Alpes, France

AlgoTherapeutix

Biotechnology
Information Technology
Pharmaceutical
$23M14 Mar 2023 Suresnes, Ile-de-France, France

Amolyt Pharma

Health Care
Medical
Therapeutics
$153M06 Jan 2023 Écully, Rhone-Alpes, France

Domain Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$46M10 May 2022 France, Grand Est, France

PathoQuest

Biotechnology
Health Care
Therapeutics
$17M09 Nov 2021 Paris, Ile-de-France, France

AI Verse

Artificial Intelligence
Machine Learning
$2M01 Sep 2021 Sophia Antipolis, Provence-Alpes-Cote d'Azur, France

Biotechnology
Therapeutics
$23M14 Dec 2020 France, Provence-Alpes-Côte d'Azur

Exotrail

Computer
Information Technology
Logistics
Software
$13M16 Jul 2020 France, Ile-de-France

MCES

eSports
Gaming
Sports
Video Games
$2M05 Jul 2020 Marseille, Provence-Alpes-Côte d'Azur, France
Crunchbase icon

Content report

The following text will be sent to our editors: